Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

NSE:INDRAMEDCO Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	2,033	49.3	614.8	616	522.6	417.4
Short-Term Investments	1,422	2,550	2,571	1,603	739.5	242.7
Cash & Short-Term Investments	3,455	2,600	3,186	2,219	1,262	660.1
Cash Growth	-25.13%	-18.40%	43.61%	75.78%	91.20%	164.89%
Accounts Receivable	1,316	1,229	845.6	642.6	746.2	481.3
Other Receivables	13.3	103	12.3	6.1	4	214.5
Receivables	1,330	1,332	857.9	648.7	750.2	695.8
Inventory	79.1	78.6	69.9	75.3	84.5	99.9
Prepaid Expenses	-	115.1	127.5	101.8	100.8	89.4
Other Current Assets	270.4	41	70.1	35.5	33.2	29.1
Total Current Assets	5,134	4,166	4,311	3,080	2,231	1,574
Property, Plant & Equipment	3,897	3,673	3,600	3,464	2,766	2,752
Long-Term Investments	2,109	2,008	549.2	605.2	455.1	230.1
Other Intangible Assets	1.9	3.4	5.9	10.5	9.6	17.1
Other Long-Term Assets	42.3	63.9	49.9	73.3	89.7	44.1
Total Assets	11,184	9,914	8,516	7,232	5,551	4,617

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	1,297	455.8	490	706.4	588.7	390.9
Accrued Expenses	32	975.4	854.9	694.3	534.9	414.9
Current Portion of Leases	37	36.8	22.2	16.8	24.8	28.3
Current Income Taxes Payable	-	-	-	5.8	44.2	-
Current Unearned Revenue	-	96.8	81	88	69.4	68.7
Other Current Liabilities	866.6	130.7	339	142.9	34.3	32.2
Total Current Liabilities	2,233	1,696	1,787	1,654	1,296	935
Long-Term Leases	309.5	331.8	305.4	322.7	-	24.8
Pension & Post-Retirement Benefits	-	-	-	-	-	153.1
Long-Term Deferred Tax Liabilities	216.4	203.7	153.9	197.2	199.8	231.9
Other Long-Term Liabilities	281.6	278.9	303	280.7	260.8	17.9
Total Liabilities	3,040	2,510	2,549	2,455	1,757	1,363

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	916.7	916.7	916.7	916.7	916.7	916.7
Retained Earnings	-	6,604	5,180	3,983	3,018	2,386
Comprehensive Income & Other	7,228	-116.8	-130	-121.8	-140.3	-48.1
Shareholders' Equity	8,144	7,404	5,967	4,778	3,795	3,254
Total Liabilities & Equity	11,184	9,914	8,516	7,232	5,551	4,617

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	346.5	368.6	327.6	339.5	24.8	53.1
Net Cash (Debt)	3,108	2,231	2,858	1,879	1,237	607
Net Cash Growth	-27.73%	-21.94%	52.12%	51.86%	103.84%	254.76%
Net Cash Per Share	33.91	24.34	31.18	20.50	13.50	6.62
Filing Date Shares Outstanding	91.75	91.67	91.67	91.67	91.67	91.67
Total Common Shares Outstanding	91.75	91.67	91.67	91.67	91.67	91.67
Working Capital	2,901	2,470	2,524	1,426	934.5	639.3
Book Value Per Share	88.77	80.76	65.09	52.12	41.39	35.50
Tangible Book Value	8,142	7,400	5,961	4,767	3,785	3,237
Tangible Book Value Per Share	88.75	80.72	65.02	52.00	41.29	35.31
Buildings	-	2,068	1,998	1,988	1,929	1,898
Machinery	-	3,638	3,190	3,247	2,855	2,603
Construction In Progress	-	27.9	325.2	4.7	25.3	-

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error